Cargando…

A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition

BACKGROUND: Malignant Mesothelioma (MM) is a highly aggressive tumor with poor prognosis. Multimodal treatments and novel molecular targeted therapies against MM are in high demand in order treat this disease effectively. We have developed a humanized monoclonal antibody YS110 against CD26 expressed...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Mutsumi, Madokoro, Hiroko, Yamada, Koji, Nishida, Hiroko, Morimoto, Chikao, Sakamoto, Michiie, Yamada, Taketo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851800/ https://www.ncbi.nlm.nih.gov/pubmed/27134571 http://dx.doi.org/10.1186/s12935-016-0310-9

Ejemplares similares

Novel Antibody-Drug Conjugate with Anti-CD26 Humanized Monoclonal Antibody and Transcription Factor IIH (TFIIH) Inhibitor, Triptolide, Inhibits Tumor Growth via Impairing mRNA Synthesis
por: Hayashi, Mutsumi, et al.
Publicado: (2019)

Nuclear Localization of CD26 Induced by a Humanized Monoclonal Antibody Inhibits Tumor Cell Growth by Modulating of POLR2A Transcription
por: Yamada, Kohji, et al.
Publicado: (2013)

CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma
por: Nishida, Hiroko, et al.
Publicado: (2018)

Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
por: Yamada, Kohji, et al.
Publicado: (2009)

P1369: HDAC INHIBITION INVOLVES CD26 EXPRESSION ON MULTIPLE MYELOMA CELLS VIA THE C-MYC/SP1-MEDIATED PROMOTER ACTIVATION AND OVERCOMES THERAPEUTIC RESISTANCE BY HUMANIZED ANTIBODY
por: Nishida, Hiroko, et al.
Publicado: (2023)

Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens
por: Hatano, Ryo, et al.
Publicado: (2019)

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma
por: Fujimoto, Nobukazu, et al.
Publicado: (2014)

Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets
por: Nishida, Hiroko, et al.
Publicado: (2019)

Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue
por: Hatano, Ryo, et al.
Publicado: (2014)

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma
por: Nakagawa, Kazuhiko, et al.
Publicado: (2021)

Establishment of anti-mesothelioma monoclonal antibodies
por: Mizutani, Natsuko, et al.
Publicado: (2016)

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma
por: AMATYA, VISHWA JEET, et al.
Publicado: (2012)

CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells
por: Okamoto, Toshihiro, et al.
Publicado: (2014)

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers
por: Angevin, Eric, et al.
Publicado: (2017)

Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies
por: Kobayashi, Eiji, et al.
Publicado: (2023)

Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target
por: Doonan, Bently P., et al.
Publicado: (2017)

Macrophage migration inhibitory factor‐CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells
por: Imaoka, Masako, et al.
Publicado: (2019)

EGCG induces human mesothelioma cell death by inducing reactive oxygen species and autophagy
por: Satoh, Motohiko, et al.
Publicado: (2013)

Augmented expression of cardiac ankyrin repeat protein is induced by pemetrexed and a possible marker for the pemetrexed resistance in mesothelioma cells
por: Qin, Yiyang, et al.
Publicado: (2017)

MiR-26a/miR-26b represses tongue squamous cell carcinoma progression by targeting PAK1
por: Wei, Zhenxing, et al.
Publicado: (2020)

Regulation of somatostatin receptor 4-mediated cytostatic effects by CD26 in malignant pleural mesothelioma
por: Yamamoto, J, et al.
Publicado: (2014)

Molecular network profiling of U373MG human glioblastoma cells following induction of apoptosis by novel marine-derived anti-cancer 1,2,3,4-tetrahydroisoquinoline alkaloids
por: Tabunoki, Hiroko, et al.
Publicado: (2012)

The effects of phenoxodiol on the cell cycle of prostate cancer cell lines
por: Mahoney, Simon, et al.
Publicado: (2014)

CD40 monoclonal antibody and OK432 synergistically promote the activation of dendritic cells in immunotherapy
por: Zhang, Juan, et al.
Publicado: (2022)

Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid types, respectively
por: Sato, Tatsuhiro, et al.
Publicado: (2021)

IL-26 mediates epidermal growth factor receptor-tyrosine kinase inhibitor resistance through endoplasmic reticulum stress signaling pathway in triple-negative breast cancer cells
por: Itoh, Takumi, et al.
Publicado: (2021)

Mast cells dysregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma
por: Ch'ng, Sydney, et al.
Publicado: (2006)

Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines
por: Teodoro, Anderson Junger, et al.
Publicado: (2012)

Ursolic acid induces cell cycle arrest and apoptosis of gallbladder carcinoma cells
por: Weng, Hao, et al.
Publicado: (2014)

Optimization of a therapeutic electromagnetic field (EMF) to retard breast cancer tumor growth and vascularity
por: Cameron, Ivan L, et al.
Publicado: (2014)

Cell-cycle synchronization reverses Taxol resistance of human ovarian cancer cell lines
por: Wang, Xueqing, et al.
Publicado: (2013)

Cd26/Dipeptidyl Peptidase IV in Context: The Different Roles of a Multifunctional Ectoenzyme in Malignant Transformation
por: Iwata, Satoshi, et al.
Publicado: (1999)

Cell migration and proliferation are regulated by miR-26a in colorectal cancer via the PTEN–AKT axis
por: Coronel-Hernández, Jossimar, et al.
Publicado: (2019)

Increased activated regulatory T cell subsets and aging Treg-like cells in multiple myeloma and monoclonal gammopathy of undetermined significance: a case control study
por: Wang, Ji-nuo, et al.
Publicado: (2018)

Novel monoclonal antibodies against thymidine kinase 1 and their potential use for the immunotargeting of lung, breast and colon cancer cells
por: Velazquez, Edwin J., et al.
Publicado: (2020)

T-cell activation via CD26 and caveolin-1 in rheumatoid synovium
por: Ohnuma, Kei, et al.
Publicado: (2006)

Metformin impairs growth of endometrial cancer cells via cell cycle arrest and concomitant autophagy and apoptosis
por: Takahashi, Akimasa, et al.
Publicado: (2014)

Casticin induces apoptosis and G0/G1 cell cycle arrest in gallbladder cancer cells
por: Song, Xiao-ling, et al.
Publicado: (2017)

The anticancer effects of ferulic acid is associated with induction of cell cycle arrest and autophagy in cervical cancer cells
por: Gao, Jinhua, et al.
Publicado: (2018)

Silencing SHMT2 inhibits the progression of tongue squamous cell carcinoma through cell cycle regulation
por: Liao, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nb1b52jc22vomsf72ert39vnnh